Figure 4 | Scientific Reports

Figure 4

From: The epicardial delivery of cardiosphere derived cells or their extracellular vesicles is safe but of limited value in experimental infarction

Figure 4

Evolution of cardiac function parameters after intrapericardial CDC, EV or Control administration in infarcted swine. (a–d) Changes over time in cardiac function parameters as measured with cardiac magnetic resonance (CMR) for the three experimental groups (CON, EV and CDC). (a) Evolution of left ventricular ejection fraction (LVEF). (b) End diastolic volume indexed to body surface area (EDVi). (c) End systolic volume indexed to body surface area (ESVi). (d) Evolution of infarct size. (e–h) Treatment effects (defined as the difference between pre-injection and 10-week values). (e) Effects on left ventricular ejection fraction (LVEF). (f) End diastolic volume indexed to body surface area (EDVi). (g) End systolic volume indexed to body surface area (ESVi). (h) Effects on infarct size.

Back to article page